Topic search: ALLERGY/IMMUNOLOGY/INFLAMMATION

Search the Journal's archive for all articles tagged as being related to your selected topic. Click here to return to the list of all topics.

Inflammation, Allergy, and Immunology Journal Articles

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Jan/Feb 2026 Pg. 32-41	Pilocarpine in the Management of Allergic Rhinosinusitis Author(s): Theodoropoulou Lydia M, Cullen Niamh A
Sep/Oct 2025 Pg. 371-386	Specific Features of Allergic Reaction to Metals: From Aetiology to Prevention Author(s): Lisiecka Maria Zofia
Jul/Aug 2025 Pg. 294-295	Dexamethasone 1-mg/mL Oral Suspension Author(s):
Mar/Apr 2024 Pg. 134	Diclofenac Sodium 1% Soft-patch Gel Author(s): Allen Loyd V Jr
Nov/Dec 2023 Pg. 454-460	Highlighting the Benefits of AlpaWash in Wound Care: Case Reports in Small Animals Author(s): Semighini Flavia, Fornaciari Lais de Azevedo, Pinheiro Vanessa, Lupatini Rodrigo, Haiub Halema, Cull Erica, Sidhu Raman
Nov/Dec 2023 Pg. 492	Hydrocortisone 2% and Menthol 0.5% in VersaPro Cream Base Author(s): Allen Loyd V Jr
Sep/Oct 2023 Pg. 368-380	Compounding for the Treatment of COVID-19 and Long COVID, Part 5: Associated Conditions, Prophylaxis, and Effective Treatment Author(s): Riepl Mike, Kaiser Joe
Sep/Oct 2023 Pg. 416	Hydrocortisone 2% in Versapro Cream Author(s): Allen Loyd V Jr
Sep/Oct 2023 Pg. 422-423	Silver Sulfadiazine 1% and Hydrocortisone 2% Gel Author(s): Allen Loyd V Jr
Sep/Oct 2023 Pg. 431-439	The Influence of Polymers, Surfactants, and Other Excipients on Naproxen Sodium Release from Matrices Prepared and the Effect of These Additives on the Swelling Rate of the Tablet Author(s): Alhmoud Hassan, Akkam Yazan, Omari Derar, Alghananim Alaa, Melhem Mohammad Bani
Jul/Aug 2023 Pg. 284-293	Compounding for the Treatment of COVID-19 and Long COVID, Part 4: The Legacy of Chronic COVID Author(s): Riepl Mike, Kaiser Joe
Jul/Aug 2023 Pg. 319	Clotrimazole 1% and Betamethasone Dipropionate 0.05% Cream Author(s): Allen Loyd V Jr
Jul/Aug 2023 Pg. 320-321	Cyclosporine Topical Gel Formulation Author(s): Allen Loyd V Jr
Jul/Aug 2023 Pg. 322	Dexamethasone 1 mg/mL in Oral Mix SF Author(s): Allen Loyd V Jr
Jul/Aug 2023 Pg. 330-339	Physiochemical and Microbiological Stability of Azathioprine Suspensions in PCCA Base, SuspendIt Author(s): Pramar Yahoda V, Mandal Tarun K, Bostanian Levon A, Kader Cyndy, Morris Tommy C, Graves Richard A
May/Jun 2023 Pg. 192-200	Compounding for the Treatment of COVID-19 and Long COVID, Part 3: The Role of Toll-like Receptors in SARS-CoV-2 Infection and COVID Development Author(s): Riepl Mike, Kaiser Joe
May/Jun 2023 Pg. 232-233	Acetaminophen 500-mg/mL Rectal Solution Author(s): Allen Loyd V Jr
May/Jun 2023 Pg. 236	Methylene Blue 5-mg Capsules Author(s): Allen Loyd V Jr
Mar/Apr 2023 Pg. 98-107	Compounding for the Treatment of COVID-19 and Long COVID, Part 2: Manifestations of Infection, Nomenclature, Transmission, and Treatment Author(s): Riepl Mike
Mar/Apr 2023 Pg. 146	Cyclosporine Topical Microemulsion Author(s): Allen Loyd V Jr
Jan/Feb 2023 Pg. 22-23	The U.S. Food and Drug Administration Takes Aim at Compounded Thyroid Hormone Author(s): Brunner Scott
Jan/Feb 2023 Pg. 57	Psoriasis Topical Ointment Author(s): Allen Loyd V Jr
Nov/Dec 2022 Pg. 446-466	Compounding with Biotechnology Products, Part 2: Product-specific Considerations Author(s): Allen Loyd V Jr
Nov/Dec 2022 Pg. 509	Curcumin 2% Topical Gel Author(s): Allen Loyd V Jr
Sep/Oct 2022 Pg. 364-368	A Compendium of Compounding Agents and Formulations, Part 5: Timolol and Beta-glucans Author(s): Riepl Mike
Sep/Oct 2022 Pg. 378-384	Compounded Medications and Probiotics for Irritable Bowel Syndrome Author(s): Narváez Katherine Rivera, Thompson Tara
Sep/Oct 2022 Pg. 430	Metronidazole 10%, Nifedipine 0.5%, Lidocaine 1.5%, and Diclofenac 3% Ointment Author(s): Allen Loyd V Jr
Jul/Aug 2022 Pg. 270-274	A Compendium of Compounding Agents and Formulations, Part 4: Nifedipine and Pentoxifylline Author(s): Riepl Mike
Jul/Aug 2022 Pg. 293-296	Compounding for Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Diseases Author(s): Harrington Amy, Williams LaVonn
Jul/Aug 2022 Pg. 318	Betamethasone Dipropionate 0.05% and Salicylic Acid 3% Lotion Author(s): Allen Loyd V Jr
Jul/Aug 2022 Pg. 320	Dexamethasone 1 mg/mL in Oral Mix Author(s): Allen Loyd V Jr
Jul/Aug 2022 Pg. 325-326	Indomethacin 1% Topical Gel Author(s): Allen Loyd V Jr
Jul/Aug 2022 Pg. 329	Psoriasis Topical Ointment Author(s): Allen Loyd V Jr
Jul/Aug 2022 Pg. 336-341	Long-term Stability of Epitheliotropic Factors in Frozen Serum Eye Drops Author(s): Sahyoun Jean-Yves, Cloutier Marc, Frenette Mathieu, Robert Marie-Claude
May/Jun 2022 Pg. 236	Cinnarizine 1 mg/mL in Oral Medium-Chain Triglycerides Anhydrous Vehicle Author(s): Allen Loyd V Jr
May/Jun 2022 Pg. 240	Sirolimus 0.1% Ointment Author(s): Allen Loyd V Jr
May/Jun 2022 Pg. 241	Valganciclovir 20 mg/mL in Ora-Plus and Ora-Sweet Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2022 Pg. 94-98	A Compendium of Compounding Agents and Formulations, Part 2: Metronidazole, Misoprostol, and Phenytoin Author(s): Riepl Mike
Mar/Apr 2022 Pg. 144	Mesalamine 100-mg/mL Suspension Enema Author(s): Allen Loyd V Jr
Mar/Apr 2022 Pg. 150-154	Stability Studies of Fludrocortisone Acetate Capsules and Fludrocortisone Acetate Titrated Powders (Powder Triturates) Author(s): Brandin Thibaut, Wasilewski Maya, Panuccio Camille, Bouguergour Cyrielle, Primas Nicolas, Lamy Edouard, Jean Christophe, Bertault-Peres Pierre, Rathelot Pascal, Curti Christophe, Vanelle Patrice
Jan/Feb 2022 Pg. 53	Ascorbic Acid 10% in Anhydrous PEG ointment Author(s): Allen Loyd V Jr
Jan/Feb 2022 Pg. 55	Diclofenac Sodium 1%-15% Topical Gel Author(s): Allen Loyd V Jr
Jan/Feb 2022 Pg. 57	Mometasone Furoate 0.1% Lotion Author(s): Allen Loyd V Jr
Sep/Oct 2021 Pg. 372-377	Compounding Pearls--Wound Care: Drugs and Formulations for Dermal Healing, Part 3: The Roles of Nitric Oxide, Sildenafil, and Naltrexone Author(s): Riepl Mike
Sep/Oct 2021 Pg. 416	Dexamethasone 1-mg/mL in Oral Mix or Oral Mix SF Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2021 Pg. 422-426	Compatibility of Gestrinone, Nimesulide, and Piroxicam in Pentravan for Transdermal and Transmucosal Application Author(s): Polonini Hudson, de Oliveira Ferreira Anderson, Dijkers Eli
Sep/Oct 2021 Pg. 431-439	Physicochemical and Microbiological Stability of Extemporaneously Compounded Hydrocortisone Oral Suspensions in PCCA Base, SuspendIt Author(s): Pramar Yashoda V, Mandal Tarun K, Bostanian Levon A, Kader Cyndy, Morris Tommy C, Graves Richard A
Jul/Aug 2021 Pg. 323	Budesonide 0.0.25% Mucoadhesive Gel Author(s): Allen Loyd V Jr
Jul/Aug 2021 Pg. 325	Hydrocortisone 2-mg/mL in Oral Mix Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2021 Pg. 328	Tacrolimus 0.1% Topical Microemulsion Author(s): Allen Loyd V Jr
May/Jun 2021 Pg. 230-231	Calculations Author(s): Stockton Shelly J
May/Jun 2021 Pg. 234	Tacrolimus 0.5 mg/mL in Ora-Plus and Simple Syrup Suspension Author(s): Allen Loyd V Jr
May/Jun 2021 Pg. 246-257	Prolonged In-use Stability of Diluted Atezolizumab in Commercial Intravenous Bags Author(s): Hui Ada, Yin Jian, Liu Wei, Zheng Kai
Jan/Feb 2021 Pg. 43	Amlodipine Besylate 0.5-mg/mL to 10-mg/mL in SuspendIt Oral Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2021 Pg. 44	Clonidine 0.01-mg/mL in Oral Mix and Oral Mix SF Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2021 Pg. 47	Metronidazole 50-mg/mL in Oral Mix and Oral Mix SF Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2021 Pg. 48-51	Design and Performance of an Inexpensive Water Activity Meter Author(s): Gilda Sagar S, Schober Joseph M, McPherson Timothy
Jul/Aug 2020 Pg. 315	Hydrocortisone Hemisuccinate 2 mg/mL or Hydrocortisone Sodium Phosphate 2 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Jul/Aug 2020 Pg. 316	Hydroxychloroquine Sulfate 25 mg/mL in Ora-Plus:Ora-Sweet SF Author(s): Allen Loyd V Jr
Jul/Aug 2020 Pg. 317	Hydroxyzine (Pamoate) 25-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2020 Pg. 320	Sumatriptan, Lidocaine Hydrochloride, Dexamethasone, Pentoxifylline, and Ibuprofen Transdermal Cream (Migraine Cream) Author(s): Allen Loyd V Jr
Jul/Aug 2020 Pg. 337-345	Evaluation of the Efficacy and Stability of Compounded Pentoxifylline-containing XemaTop for Psoriasis Author(s): Song Guiyun, Ip Kendice, Shan Ashley, Banov Daniel, Bassani August S
May/Jun 2020 Pg. 225	Dexamethasone 1 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
May/Jun 2020 Pg. 229	Prednisolone 1 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Mar/Apr 2020 Pg. 94-96	Low-dose Naltrexone Therapy for Psoriasis Author(s): Weinstock Leonard B, Cottel Jill, Aldridge Lindsey, Egeberg Alexander
Mar/Apr 2020 Pg. 163-167	Feasibility Study of Asthma Cream Author(s): Kuang Andrew
Jan/Feb 2020 Pg. 57	Hydrocortisone 2%, Iodoquinol 1% Metronidazole 10%, and Zinc Oxide 2% in Polyethylene Glycol Ointment Author(s): Allen Loyd V Jr
Jan/Feb 2020 Pg. 59	LCD 5%, Salicylic Acid 6% in Clobetasol Propionate 0.05% Ointment Author(s): Allen Loyd V Jr
Nov/Dec 2019 Pg. 487	Prednisolone Sodium Phosphate 1.4 mg/mL in SyrSpend SR pH4, Cherry Flavored Author(s): Allen Loyd V Jr
Nov/Dec 2019 Pg. 490	Sulfasalazine 100 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Nov/Dec 2019 Pg. 491	Tacrolimus Monohydrate 1 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Sep/Oct 2019 Pg. 410	Oxandrolone 3 mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2019 Pg. 229	Calculations Author(s): Stockton Shelly J
May/Jun 2019 Pg. 231	Chloroquine Phosphate 15 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
May/Jun 2019 Pg. 233	Flunisolide Nasal Spray Author(s): Allen Loyd V Jr
May/Jun 2019 Pg. 235	Methotrexate 2-mg/mL Oral Solution Author(s): Allen Loyd V Jr
Mar/Apr 2019 Pg. 149	Dexamethasone 2 mg/g Topical Paste, Veterinary Author(s): Allen Loyd V Jr
Mar/Apr 2019 Pg. 150	Ketoprofen 10% in Pluronic Lecithin Organogel Author(s): Allen Loyd V Jr
Mar/Apr 2019 Pg. 153	Tacrolimus 0.5 mg/mL in Oral Mix Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2019 Pg. 14-21	The History, Symptoms, Causes, Risk Factors, Types, Diagnosis, Treatments, and Prevention of Gout, Part 2 Author(s): Williams LaVonn A
Jan/Feb 2019 Pg. 52	Ketoprofen 10% in Pluronic Lecithin Organogel Author(s): Allen Loyd V Jr
Jan/Feb 2019 Pg. 53	Ketoprofen 20-mg/mL in SyrSPend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2018 Pg. 495	Hydrocortisone 2 mg/mL in Inorpha Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2018 Pg. 497	Prednisone 5 mg/mL ir Oral Mix Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2018 Pg. 270-278	Compounded Low-dose Naltrexone for the Treatment of Guttate Psoriasis: A Case Report Author(s): Muller George, Grieshaber Robert, Talley J Floyd, Riepl Mike, Fellows Don
Jul/Aug 2018 Pg. 284-287	The History, Symptoms, Causes, Risk Factors, Types, Diagnosis, Treatments, and Prevention of Gout, Part 1 Author(s): Williams LaVonn
Jul/Aug 2018 Pg. 317	Budesonide 1-mg//10-mL Mucolox Oral Suspensions Author(s): Allen Loyd V Jr
Jul/Aug 2018 Pg. 319	Ketoprofen 10% in Pluronic Lecithin Organogel Author(s): Allen Loyd V Jr
Mar/Apr 2018 Pg. 152	Spironolactone 5-mg/mL in Suspendit Oral Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2018 Pg. 153	Trilostane 5-mg/mL in Cod Liver Oil Suspension (Vet) Author(s): Allen Loyd V Jr
Jan/Feb 2018 Pg. 51	Mercaptopurine 50 mg/mL in Ora-Sweet and Ora-Plus Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2018 Pg. 54	Naproxen 25 mg/mL in Oral Mix or Oral Mix SF Author(s): Allen Loyd V Jr
Jan/Feb 2018 Pg. 55	Penicillamine-D 50 mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2018 Pg. 58	Thalidomide 20 mg/mL in Ora-Plus and Ora-Sweet Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2018 Pg. 66-75	Stability of an Alcohol-free, Dye-free Hydrocortisone (2 mg/mL) Compounded Oral Suspension Author(s): Manchanda Arushi, Laracy Melissa, Savji Taslim, Bogner Robin H
Jan/Feb 2018 Pg. 76-85	Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Palonosetron Hydrochloride Injection and Dexamethasone Sodium Phosphate Injection Author(s): Wu George, Powers Dan, Yeung Stanley, Chen Frank
Jan/Feb 2018 Pg. 86-94	Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Granisetron Hydrochloride Author(s): Wu George, Powers Dan, Yeung Stanley, Chen Frank, Neelon Kelly
Nov/Dec 2017 Pg. 494	Hydroxychloroquine Sulfate 25 mg/mL in Oral Mix or Oral Mix SF Author(s): Allen Loyd V Jr
Nov/Dec 2017 Pg. 497	Tolmetin 400-mg Capsules Author(s): Allen Loyd V Jr
Jul/Aug 2017 Pg. 312	Betamethasone 0.1% and Neomycin 0.6% Gel-Cream Author(s): Allen Loyd V Jr
Jul/Aug 2017 Pg. 319	Tacrolimus 0.06% Ophthalmic Drops Author(s): Allen Loyd V Jr
Jul/Aug 2017 Pg. 321	Tranilast 8% Pluronic Lecithin Organogel Gel Author(s): Allen Loyd V Jr
Jul/Aug 2017 Pg. 322-329	Physical and Chemical Stability of Budesonide Mucoadhesive Oral Suspensions (MucoLox) Author(s): Ip Kendice, Carvalho Maria, Shan Ashley, Banov Daniel
Jul/Aug 2017 Pg. 334-338	Stability of Spironolactone Oral Suspension in PCCA Base, SuspendIt Author(s): Graves Richard, Phan Kelly V, Bostanian Levon A, Mandal Tarun K, Pramar Yashoda V
May/Jun 2017 Pg. 235	Meloxicam 1% Topical Gel Author(s): Allen Loyd V Jr
Mar/Apr 2017 Pg. 146	Azathioprine 10-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2017 Pg. 62	Infliximab 1% Ophthalmic Solution Author(s): Allen Loyd V Jr
Sep/Oct 2016 Pg. 410	Naproxen 5% Cream Author(s): Allen Loyd V Jr
Jul/Aug 2016 Pg. 333-337	Evaluation of the Antibacterial Activity of Green Propolis Extract and Meadowsweet Extract Against Staphylococcus aureus Bacteria: Importance in Would Care Compounding Preparations Author(s): Lupatini Nogueira Rodrigo José, Danopoulos Panagiota, Swikidisa Rosita, Alves Pinheiro Vanessa
May/Jun 2016 Pg. 228	Dexamethasone 0.1%, Neomycin 0.35%, and Polymixin 10,000 Units/g Ophthalmic Ointment Author(s): Allen Loyd V Jr
May/Jun 2016 Pg. 230	Indomethacin Gel Author(s): Allen Loyd V Jr
May/Jun 2016 Pg. 232	Montelukast Sodium 5-mg Fast-Dissolving Film Author(s): Allen Loyd V Jr
Mar/Apr 2016 Pg. 144	Blue Goo Anti-Itch Gel Author(s): Allen Loyd V Jr
Mar/Apr 2016 Pg. 146	Medicated Polyox Bandage for Skin Ulcers Author(s): Allen Loyd V Jr
Jan/Feb 2016 Pg. 6-10	Extemporaneous Compounding of Oral Acitretin Suspension for Pediatric Patient with Generalized Pustular Psoriasis Author(s): Choo Winnie
Jan/Feb 2016 Pg. 51	Dexamethasone, Neomycin, and Polymyxin Ophthalmic Ointment Author(s): Allen Loyd V Jr
Nov/Dec 2015 Pg. 508	Dexamethasone Sodium Phosphate Ophthalmic Solution: Equivalent to 0.1% Dexamethasone Phosphate Author(s): Allen Loyd V Jr
Sep/Oct 2015 Pg. 357-365	Novel Approaches to Topical Psoriasis Therapy Author(s): Koyama Gregory, Liu Jenny, Scaffidi Alyse, Khazraee Maryam, Epstein Benjamin
Sep/Oct 2015 Pg. 405	Betamethasone Valerate 0.12%, Tranilast 1% Topical Gel Author(s): Allen Loyd V Jr
Jul/Aug 2015 Pg. 333	Tacrolimus Capsules, 0.5 mg, 1 mg, or 5 mg Author(s): Allen Loyd V
Jul/Aug 2015 Pg. 337-339	Stability of Prednisone in Oral Mix Suspending Vehicle Author(s): Friciu Mihaela, Plourde Kevin, Leclair Grégoire, Danapoulos Panagiota, Savji Taslim
May/Jun 2015 Pg. 243	Lidocaine Hydrochloride 2% Viscous Oral Topical Solution Author(s): Allen Loyd V Jr
May/Jun 2015 Pg. 261-267	Physico-chemical Stability of MabThera Drug-product Solution for Subcutaneous Injection under In-use Conditions with Different Administration Materials Author(s): Mueller Claudia, Dietel Elde, Heynen Severin R, Nalenz Heiko, Goldbach Pierre, Mahler Hanns-Christian, Schmidt Johannes, Grauschopf Ulla, Schoenhammer Karin
Jan/Feb 2015 Pg. 61	Azathioprine 50-mg Capsules Author(s): Allen Loyd V Jr
Jan/Feb 2015 Pg. 66	Hydroxychloroquine Sulfate 200-mg Capsules Author(s): Allen Loyd V Jr
Jan/Feb 2015 Pg. 73-77	Physicochemical and Microbiological Stability of Azathioprine in InOrpha Suspending Agent Studied Under Various Conditions Author(s): Amin Alexandre, Bourget Philippe, Vidal Fabrice, Cartier Francois, Beauvais Raphaelle, Do Nascimento Afonso Veronica
Sep/Oct 2014 Pg. 370-377	Autologous Serum Eye Drops for Severe Dry Eye Syndrome in a Patient with Chronic Graft-vs-Host Disease: A Case Report Author(s): Mixon Bill, Mixon Jan, Isbey Edward K III, Sprinkle Shari
Sep/Oct 2014 Pg. 411	Ephedrine Sulfate 50-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2014 Pg. 418-426	Stability and In Vitro Toxicity of an Infliximab Eye Drop Formulation Author(s): Robert Marie-Claude, Spurr-Michaud Sandra, Frenette Mathieu, Young David, Gipson Ilene K, Dohlman Claes H
Sep/Oct 2014 Pg. 427-431	Physicochemical and Microbiological Stabilities of Hydrocortisone in InOrpha Suspending Agent Studied Under Various Condition Author(s): Bourget Philippe, Amin Alexandre, Vidal Fabrice, Pieyre Manon, Dosso El Ourmar, Beauvais Raphaelle, Loeuillet Richard
Jul/Aug 2014 Pg. 287-290	Oral Mucosal Immunotherapy Using a Toothpaste Delivery System for the Treatment of Allergic Rhinitis Author(s): Reisacher William, Rudner Shara, Kotik Viktoriya
Jul/Aug 2014 Pg. 327	Choline Magnesium Trisalicylate Liquid Author(s): Allen Loyd V Jr
Jul/Aug 2014 Pg. 328	Denileukin Diftitox 150-mcg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2014 Pg. 348-350	Evaluation of the Stability of Ketoprofen in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-use Date Author(s): Peacock Gina F, Sauvageot Jurgita, Addo Richard T
Nov/Dec 2013 Pg. 501	Cortisone Acetate 25-mg Capsules Author(s): Allen Loyd V Jr
Nov/Dec 2013 Pg. 504	Hydrocortisone 50-mg/mL Injection (as the Sodium Succinate) Author(s): Allen Loyd V Jr
Sep/Oct 2013 Pg. 380-383	Use of Topical Metronidazole in the Treatment of Anorectal Crohn's Disease Author(s): McElhiney Linda F
Sep/Oct 2013 Pg. 419	Indomethacin 1-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2013 Pg. 421	Methotrexate 25-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2013 Pg. 422	Phenylephrine Hydrochloride 10-mg/mL Injection Author(s): Allen Loyd V Jr
May/Jun 2013 Pg. 234	Mercaptopurine 75-mg Capsules Author(s): Allen Loyd V Jr
May/Jun 2013 Pg. 236	Prednisone 10-mg Capsules Author(s): Allen Loyd V Jr
Jan/Feb 2013 Pg. 39-44	Adrenal Fatigue Author(s): Allen Loyd V Jr
Jan/Feb 2013 Pg. 67	Ibuprofen 10-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2013 Pg. 74-85 View Sample	The Effects of Compounded Bioidentical Transdermal Hormone Therapy on Hemostatic, Inflammatory, and Immune Factors; Cardiovascular Biomarkers; Quality of Life Measures; and Health Outcomes in Perimenopausal and Postmenopausal Women Author(s): Stephenson Kenna, Neuenschwander Pierre F, Kurdowska Anna K
Nov/Dec 2012 Pg. 462-469	Recurrent Aphthous Stomatitis: Topical Treatment with Minocycline and Other Evidence-based Agents Author(s): Zur Eyal
Nov/Dec 2012 Pg. 502	Azathioprine 10-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2012 Pg. 386-393	Topical Use of Sodium Cromoglicate (Cromolyn Sodium) to Treat Atopic Dermatitis and Other Skin Allergies Author(s): Zur Eyal
Jul/Aug 2012 Pg. 288-293	Eosinophilic Esophagitis: Treatment with Oral Viscous Budesonide Author(s): Zur Eyal
Jul/Aug 2012 Pg. 332	Betamethasone 0.6-mg/5-mL Syrup Author(s): Allen Loyd V Jr
Jul/Aug 2012 Pg. 334	Diphenhydramine Hydrochloride 50-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2012 Pg. 337	Ketorolac Tromethamine 15-mg/mL Injection Author(s): Allen Loyd V Jr
May/Jun 2012 Pg. 210-218	Treatment and Prevention of Insect Bites: Mosquitoes Author(s): Williams LaVonn A, Allen Loyd V Jr
May/Jun 2012 Pg. 242	Famotidine 10-mg/mL Injection Author(s): Allen Loyd V Jr
May/Jun 2012 Pg. 244	Naloxone Hydrochloride 1-mg/mL Injection Author(s): Allen Loyd V Jr
May/Jun 2012 Pg. 246	Prochlorperazine 5-mg/mL Injection Author(s): Allen Loyd V Jr
May/Jun 2012 Pg. 247	Ranitidine 25-mg/mL Injection Author(s): Allen Loyd V Jr
May/Jun 2012 Pg. 258-261	Influence of Temperature on the Thirty-Day Chemical Stability of Extemporaneously Prepared Dexamethasone Paste Author(s): Dudley Richard, McDowell Brean, Mahl Carissa, Sarkar Arindam Basu
Mar/Apr 2012 Pg. 163	Promethazine Hydrochloride 50-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2012 Pg. 22-33	Oral Mucositis: Etiology and Clinical and Pharmaceutical Management Author(s): Zur Eyal
Nov/Dec 2011 Pg. 458-463	Infantile Hemangiomas, Part 2: Topical Treatment with Beta Blockers Author(s): Zur Eyal
Nov/Dec 2011 Pg. 505	Oxandrolone 2-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Nov/Dec 2011 Pg. 506	Thioguanine 20-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2011 Pg. 515-520	Physiochemical Stability of Diluted Trastuzumab Infusion Solutions in Polypropylene Infusion Bags Author(s): Kaiser Jeanette, Kramer Irene
Sep/Oct 2011 Pg. 424	Rebamipide Rectal Enema Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2011 Pg. 336	Cromolyn Sodium 50-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2011 Pg. 338	Hydrocortisone 100-mg/60-mL Retention Enema Author(s): Allen Loyd V Jr
Jul/Aug 2011 Pg. 339	Magnesium Sulfate Paste Author(s): Allen Loyd V Jr
Jul/Aug 2011 Pg. 302-307	Treating Inner Ear Disorders with Intratympanic Drug Administration Author(s): McElhiney Linda F
Jul/Aug 2011 Pg. 340	Methylprednisolone 4-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2011 Pg. 341	Oxandrolone 1-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2011 Pg. 204-213	Treatment Options for Psoriasis Author(s): Williams LaVonn A, Humphreys Erica
May/Jun 2011 Pg. 243	Diclofenac Sodium 1% Topical Gel Author(s): Allen Loyd V Jr
May/Jun 2011 Pg. 244	Ibuprofen 5% Topical Cream Author(s): Allen Loyd V Jr
May/Jun 2011 Pg. 249	Triamcinolone 0.1% Lotion Author(s): Allen Loyd V Jr
Jan/Feb 2011 Pg. 13-18	Current Concepts in the Treatment of Recurrent Aphthous Ulcers Author(s): Bramwell Bethany L, Williams LaVonn A
Jan/Feb 2011 Pg. 64	Diclofenac Sodium 10-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2011 Pg. 65	Hydrocortisone Acetate 1% Gel, Alcohol-Free Author(s): Allen Loyd V Jr
Jan/Feb 2011 Pg. 66	Ibuprofen 5% Gel Author(s): Allen Loyd V Jr
Jan/Feb 2011 Pg. 68	Methotrexate 30-mg/g Topical Gel Author(s): Allen Loyd V Jr
Jan/Feb 2011 Pg. 69	Piroxicam 1% Gel Author(s): Allen Loyd V Jr
Jan/Feb 2011 Pg. 78-80	Chemical Stability of Brompheniramine Maleate in an Oral Liquid Dosage Form Author(s): Gupta Vishnu D, Gupta Vikas S
Nov/Dec 2010 Pg. 517	Capsaicin 0.05% Clear Medication Stick Author(s): Allen Loyd V Jr
Nov/Dec 2010 Pg. 521	Ketoprofen 2% Oral Gel Author(s): Allen Loyd V Jr
Nov/Dec 2010 Pg. 516	Bromhexine Hydrochloride 0.8-mg/mL Syrup Author(s): Allen Loyd V Jr
Nov/Dec 2010 Pg. 520	Ketoprofen 5% and Lidocaine Hydrochloride 0.5% Topical Gel Author(s): Allen Loyd V Jr
Sep/Oct 2010 Pg. 420	Alpha-Bisabolol Mouthwash Author(s): Allen Loyd V Jr
Sep/Oct 2010 Pg. 430-435	Quality Control and Physical and Chemical Stability of Hydrocortisone Oral Suspension: An Interlaboratory Study Author(s): Santoveña A, Llabrés M, Fariña JB
Sep/Oct 2010 Pg. 427	Haloperidol 0.416-mg/mL, Hyoscine 4.9-mg/mL, and Tramadol 16.67-mg/mL in 0.9% Sodium Chloride Injection Author(s): Allen Loyd V Jr
Jul/Aug 2010 Pg. 336	Antazoline Phosphate and Xylometazoline Hydrochloride Ophthalmic Drops Author(s): Allen Loyd V Jr
Mar/Apr 2010 Pg. 112-115	Case Report: The Use of Inhaled Cyclosporine to Treat Bronchiolitis Obliterans Syndrome in a Lung Transplant Patient Author(s): McElhiney Linda F
Mar/Apr 2010 Pg. 151	Acyclovir 200-mg/5-mL Oral Suspension (From the Injection) Author(s): Allen Loyd V Jr
Jan/Feb 2010 Pg. 68	Ketoprofen 100-mg/5-mL Mouth Rinse Author(s): Allen Loyd V Jr
Jan/Feb 2010 Pg. 74	Tobramycin Sulfate 0.3% and Diclofenac Sodium 0.1% Ophthalmic Solution Author(s): Allen Loyd V Jr
Sep/Oct 2009 Pg. 372-381	A Review of Stomatitis and Treatment in Cats Author(s): Ray Jody D, Jordan Dinah G, Eubanks Diana L, Crosswhite Megan E
Sep/Oct 2009 Pg. 386-389	Skin Disorders in Horses; Case Report: Tripelennamine in the Treatment of Skin Disorders in Horses Author(s): Williams LaVonn A, Fokken Dawn
Sep/Oct 2009 Pg. 404-409	An Abridged History of Aspirin Author(s): Vance Dwight A
Jul/Aug 2009 Pg. 335	Dexamethasone and Furosemide Injection Author(s): Allen Loyd V Jr
Mar/Apr 2009 Pg. 157	Metronidazole 2.1-mg/mL in 5.25% Dextrose Injection Author(s): Allen Loyd V Jr
Mar/Apr 2009 Pg. 158	Nicotine Rectal Enema Author(s): Allen Loyd V Jr
Jan/Feb 2009 Pg. 69	Diphenhydramine Hydrochloride 25-mg Gelatin Troches Author(s): Allen Loyd V Jr
Nov/Dec 2008 Pg. 482-487	Compounding Challenges for Immunocompromised Patients Author(s): McElhiney Linda F
Sep/Oct 2008 Pg. 426-430	Excipient Choices for Special Populations Author(s): Nagel-Edwards Karen M, Ko James Y
Sep/Oct 2008 Pg. 451	Flurandrenolide Topical Film Author(s): Allen Loyd V Jr
Jul/Aug 2008 Pg. 364	Zirconium Oxide Lotion Author(s): Allen Loyd V Jr
Jul/Aug 2008 Pg. 295-304	Transdermal Progesterone: Effects on Menopausal Symptoms and on Thrombotic, Anticoagulant, and Inflammatory Factors in Postmenopausal Women Author(s): Stephenson Kenna, Neuenschwander Pierre F, Kurdowska Anna K, Pinson Barbara, Price Carol
Jul/Aug 2008 Pg. 334-337	Using Readily Available Technology to Start or Enhance Pharmacy-Based Immunization Author(s): Westrick Salisa C, Felkey Bill G
Jul/Aug 2008 Pg. 360	Tretinoin and (-)Alpha-Bisabolol Gel Author(s): Allen Loyd V Jr
Jul/Aug 2008 Pg. 361	Tretinoin and Dexpanthenol Gel Author(s): Allen Loyd V Jr
Jan/Feb 2008 Pg. 64	Cyclosporine Topical Gel Author(s): Allen Loyd V Jr
Jan/Feb 2008 Pg. 65	Diclofenac Sodium 1% Soft-Patch Gel Author(s): Allen Loyd V Jr
Jan/Feb 2008 Pg. 66	Diclofenac Sodium 1% Soft-Patch Lipophilic Gel Author(s): Allen Loyd V Jr
Jan/Feb 2008 Pg. 69	Flosulide 10-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2008 Pg. 71	Piroxicam 1% Soft-Patch Lipophilic Gel Author(s): Allen Loyd V Jr
Jan/Feb 2008 Pg. 72	Piroxicam 1% Soft-Patch Topical Gel Author(s): Allen Loyd V Jr
Sep/Oct 2007 Pg. 419	Betamethasone Valerate 0.1% Topical Gel Author(s): Allen Loyd V Jr
Sep/Oct 2007 Pg. 421	Diclofenac Sodium 75-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2007 Pg. 423	Hydrocortisone 0.5% Ethanolic Gel Author(s): Allen Loyd V Jr
Jul/Aug 2007 Pg. 347-348	Chemical Stability of Cyproheptadine Hydrochloride in an Oral Liquid Dosage Form Author(s): Gupta Vishnu D
May/Jun 2007 Pg. 259-261	Chemical Stability of Hydrocortisone in an Oral Liquid Dosage Form without Suspending Agents Author(s): Gupta Vishnu D
Mar/Apr 2007 Pg. 154	Aspirin 80-mg/5-mL Oral Liquid, Anhydrous Author(s): Allen Loyd V Jr
Mar/Apr 2007 Pg. 132-135	Innovative Uses of Compounded Tranilast: An Interview with Compounding Pharmacist Larry J. Frieders, RPh Author(s): Vail Jane
Mar/Apr 2007 Pg. 163	Triprolidine Hydrochloride 0.25-mg/mL Syrup Author(s): Allen Loyd V Jr
Jan/Feb 2007 Pg. 72	Dexamethasone 1-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jan/Feb 2007 Pg. 77	Prednisone 10-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jan/Feb 2007 Pg. 78	Prednisolone Sodium Phosphate 10-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Nov/Dec 2006 Pg. 454	Cyclophosphamide 2-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Nov/Dec 2006 Pg. 458	Indomethacin 2-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Nov/Dec 2006 Pg. 460	Terbutaline Sulfate 1-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Sep/Oct 2006 Pg. 392-395	In Vitro Transdermal Diffusion of Zileuton from a Topical Gel Author(s): Bigeleisen Paul E
Jul/Aug 2006 Pg. 300	Dapsone 2-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
May/Jun 2006 Pg. 195-200	Probiotic Therapy, Part 2: Clinical Perspectives Author(s): Vail Jane
May/Jun 2006 Pg. 234-236	Physical and Chemical Stability of Palonosetron Hydrochloride with Dacarbazine and with Methylprednisolone Sodium Succinate During Simulated Y-Site Administration Author(s): Trissel Lawrence A, Xu Quanyun A, Zhang Yanping
May/Jun 2006 Pg. 237-239	Chemical Stability of Diphenhydramine Hydrochloride from an Elixir and Lidocaine Hydrochloride from a Viscous Solution when Mixed Together Author(s): Gupta Vishnu D
Mar/Apr 2006 Pg. 141	Mycophenolate Mofetil 50-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Mar/Apr 2006 Pg. 107-111	Probiotic Therapy, Part 1: Beneficial Bacteria Improve Health, Save Lives Author(s): Vail Jane
Jan/Feb 2006 Pg. 14-18 View Sample	Transdermal Administration of Anti-inflammatory Medications in Sports Injuries: Use of Iontophoresis and Phonophoresis to Enhance Delivery Author(s): Heim Bob
Jan/Feb 2006 Pg. 64	Mercaptopurine 50-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
May/Jun 2005 Pg. 226	Dexamethasone Oral Powder 10-mg Units, Veterinary Author(s): Allen Loyd V Jr